DIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI.

Similar documents
Echocardiographic Correlates of Pulmonary Artery Systolic Pressure

Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

HTA ET DIALYSE DR ALAIN GUERIN

PRELIMINARY STUDIES OF LEFT VENTRICULAR WALL THICKNESS AND MASS OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS USING M-MODE ECHOCARDIOGRAPHY

Dr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA.

Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

The role of physical activity in the prevention and management of hypertension and obesity

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

Coronary artery disease (CAD) risk factors

ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods

Interventricular Septum Thickness Predicts Future Systolic Hypertension in Young Healthy Pilots

Hypertensive heart disease and failure

Internet Journal of Medical Update, Vol. 3, No. 2, Jul-Dec 2008

Prevalence of left ventricular hypertrophy in a hypertensive population

Importance of Ambulatory Blood Pressure Monitoring in Adolescents

Drug treatments in hypertension outcome studies

How well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study

Seminars in Cardiology, 2003, Vol. 9, No. 3 ISSN SEX-SPECIFIC ANALYSIS OF LEFT VENTRICULAR GEOMETRY IN A POPULATION STUDY IN TALLINN

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Left ventricular mass in offspring of hypertensive parents: does it predict the future?

Egyptian Hypertension Guidelines

Masked Hypertension and Aortic Coarctation: Impact on Ventricular Function and Morphology

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

Antihypertensive Trial Design ALLHAT

Echocardiography analysis in renal transplant recipients

Individual Study Table Referring to Part of Dossier: Volume: Page:

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

Right Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa

Summary of recommendations

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes

BRIEF COMMUNICATIONS. KEY WORDS: Ambulatory blood pressure monitoring, placebo effect, antihypertensive drug trials.

HYPERTENSION AND HEART FAILURE

Dr. Dermot Phelan MB BCh BAO PhD European Society of Cardiology 2012

Journal of the American College of Cardiology Vol. 33, No. 6, by the American College of Cardiology ISSN /99/$20.

Prognostic significance of blood pressure measured on rising

Journal of the American College of Cardiology Vol. 41, No. 6, by the American College of Cardiology Foundation ISSN /03/$30.

The athlete s heart: Different training responses in African and Caucasian male elite football players

Relationship between cardiovascular risk factors and traditional Chinese constitution in subjects with high-normal blood pressure

Abstract ESC Pisa

Mareomi Hamada, Go Hiasa, Osamu Sasaki, Tomoaki Ohtsuka, Hidetoshi Shuntaro Ikeda, Makoto Suzuki, Yuji Hara, and Kunio Hiwada

Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient

Slide notes: References:

ONLINE DATA SUPPLEMENT. Impact of Obstructive Sleep Apnea on Left Ventricular Mass and. Diastolic Function

Brachial artery hyperaemic blood flow velocity and left ventricular geometry

SUPPLEMENTAL MATERIAL

THE HEART AND HYPERTENSION. Philippe Gosse Hypertension Unit University Hospital Bordeaux

Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo?

Update on Current Trends in Hypertension Management

Diastolic Heart Failure

LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM

Clinical Study Synopsis

Comparison of 44-Hour and Fixed 24-Hour Ambulatory Blood Pressure Monitoring in Dialysis Patients

Patterns of Left Ventricular Remodeling in Chronic Heart Failure: The Role of Inadequate Ventricular Hypertrophy

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

How do we diagnose hypertension today? Presentation Subtitle

Predictors of unfavorable outcome after atrial septal defect closure in adults

Aortic stenosis (AS) is common with the aging population.

In white mild to moderate hypertensive patients. Nifedipine Versus Captopril in the Management of Moderate Hypertension in Black ratients

Value of cardiac rehabilitation Prof. Dr. L Vanhees

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

80 Appendix A. Fig. A.1 Repository of ABPM information containing measurements of the BP

Abstract nr AHA, Chicago November European Heart Journal Cardiovascular Imaging, in press. Nr Peter Blomstrand

DIURNAL VARIATIONS IN BLOOD PRESSURE AND THEIR RELATION WITH CAROTID ARTERY INTIMA-MEDIA THICKENING

JMSCR Vol 04 Issue 05 Page May 2016

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

How Low Do We Go? Update on Hypertension

Byeong-Keuk Kim, MD, PhD. Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Medicine, Seoul, Korea

Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.

Characteristics and Future Cardiovascular Risk of Patients With Not-At- Goal Hypertension in General Practice in France: The AVANT AGE Study

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

5.2 Key priorities for implementation

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

Chapter Two Renal function measures in the adolescent NHANES population

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study

Clinical cases with Coversyl 10 mg

Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU

Jared Moore, MD, FACP

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

Prognostic Significance of Left Ventricular Diastolic Dysfunction in Essential Hypertension

Prospective Study of the Changes in Left Ventricular Mass and Geometry Patterns in Hypertensive Patients During 5 Years of Follow-up

Clinical Investigations

AFRICA CARDIOVASCULAR JOURNAL OF AFRICA Vol 23, No 3, April 2012

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function:

& Wilkins. a Division of Cardiology, Schulich Heart Centre, b Institute for Clinical and

Online Appendix (JACC )

Introduction. In Jeong Cho, MD, Wook Bum Pyun, MD and Gil Ja Shin, MD ABSTRACT

Rationale: Objectives: Indication: Diabetes Mellitus, Type 2 Study Investigators/Centers: 300 physicians in 292 clinics Research Methods: Data Source:

Guidelines on cardiovascular risk assessment and management

THE IMPACT OF CCB AND RAS INHIBITOR COMBINATION THERAPY TO PREVENT CKD INCIDENCE IN HYPERTENSION AND ADVANCED ATHEROSCLEROSIS

Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients

Dr Doris M. W Kinuthia

Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan

Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.

Transcription:

DIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI. Franco Cipollini, Carlo Porta, Enrica Arcangeli, Carla Breschi, & Giuseppe Seghieri Azienda USL 3, Ambulatorio per l Ipertensione Arteriosa, Spedali Riuniti, Pistoia

Introduction and Aims of the Study There are evidences to support the hypothesis that women myocardial mass is more susceptible than the male heart to hypertrophy in response to blood pressure load in either humans or in animal models. Furthermore the prediction of cardiovascular morbidity and mortality exerted by left ventricular hypertrophy (LVH) in patients with hypertension seems to be more pronounced in women than in men. The present study was therefore undertaken to investigate the different response between blood pressure, recorded by 24-hour monitoring, and LVM, measured by echocardiographic method, in a population of hypertensive outpatients.

Subjects & Methods (1) Population under study The population under study comprised all patients who were consecutively referred by their general practitioners to the outpatient clinic for arterial hypertension of our Hospital (Spedali Riuniti, Pistoia), in order to confirm borderline or white coat hypertension or to modify treatment, where the response to the antihypertensive therapy prescribed at home was judged inadequate. Home therapy was constituted by diuretics, ACE inhibitors, Ca channel blockers and α 1 -blockers alone or in various combination. No difference was present in type of therapy between genders. Diagnosis of diabetes was done according to the anamnestic recall by patients or by measuring fasting plasma glucose (> 7mmol/l).

Subjects & Methods (2) Blood pressure was recorded in all patients by a same physician, with a mercury sphygmomanometer, in the sitting position after 10 min rest. The mean of 3 measurements was taken for analysis. Twenty-four hour ambulatory BP was recorded by using an oscillometric device (model SpaceLabs 90207) that was set to take BP readings every 15 min during the day and every 30min during the night. Left ventricular mass (LVM) was measured through echocardiographic method using Devereux s formula [LVM (g)=0.80x(1.04x(d+p+s) 3 -D 3 ) +0.6] and indexed by height 2.7. Comparison between means was performed by using Student s t test. χ 2 test was used to evaluate the significance of differences in proportions. Relations were assessed by Pearson s r correlations coefficients. Multivariate regression analysis model was used to evaluate multiple r and percentage of explained variance of the dependent variablesl. Relative risks, defined as odds ratio, were calculated by using a multiple logistic analysis model. All values are expressed as mean ± SD. The statistical tests were performed by using SAS software for Windows, version 8.2 (SAS Institute Inc., Cary, NC, USA).

Results (1) Table 1, shows that women were significantly older, while there was no difference between the sexes in body mass index (BMI) or prevalence of obesity. Twenty-four-hour systolic BP was slightly higher and 24-h diastolic BP significantly lower in women, since, consequently, pulse BP was markedly higher in these latter. Prevalence of hypertension expressed as mean systolic 24-hour BP>125mmHg and/or 24-hour diastolic BP>80mmHg, as well as of diabetes, and previous drug treatment were similar in both genders The left ventricular end-diastolic septal thickness, the posterior wall thickness, as well as the value of not indexed LVM, all measured by echocardiographic method, were significantly higher in men, while after correction for body surface or for height 2.7 LVM values were all together each other not different (Table 2). Left ventricular hypertrophy, present in the 22.5% of males and in 36.4% of females with a near significant preponderance among these latter (p=0.06), was eccentric in over the 70% of cases in both sexes (Table 2). According to the univariate analysis, LVM, indexed by height 2.7 was significantly related to age and to mean 24-hour systolic and pulse BP, while 24-hour diastolic BP was weakly inversely related with LVM only in the female group (r=-0.28; p=0.02). Correlation coefficients between 24-hour pulse pressure and LVM were higher in women than in men (Table 3). These relations remained significant, even after adjusting for possible confounders, as suggested by two separate multiple regression models: the first, which included both systolic and diastolic 24- hour BP into the set of independent covariates and the second which included the 24-hour pulse BP (Table 4).

Results (2) Percentage of LVM variance explained by BP values, as expressed by the multiple regression analyses, was on average higher among women than among men (about 55% vs. 45%), and once again 24-hour pulse BP was about sevenfold more important in predicting LVM variance in women than in men (40.77% vs. 6.19%) (Fig. 1). The percent increase in the relative risk of developing LVH (left ventricular mass 47 g/m 2.7 in women and 50 g/m 2.7 in men), expressed by odds-ratios adjusted for main confounders, and estimated for every 1mmHg increase, was ~2.7 times higher in women than in men, either considering the mean 24-hour systolic BP (21.4% vs 8.2%) or the 24-hour mean pulse BP (24.4% vs. 9%) (Table 5). Relative risk of developing LVH due to the increase in 24-hour diastolic blood pressure values was similar in men and in women (~8-10% for every 1mmHg increase), even considering that the odds-ratio value did not reach the full significance in women (10.8; 95%CI: 0.998-1.230; Table 5). Non dipping status was related to a significantly higher relative risk of having LVH in women (Odds ratio: 7.88; 95% CI: 1.37-45.4) after adjusting for age, diabetes, BMI and therapy, while it wasn t in men (Odds ratio: 2.47; 95% CI: 0.67-9.13). All these differences were even more evident including only the hypertensive patients.

Conclusions 1. Pulse pressure was more elevated in women, as compared to men, due to a lower diastolic BP in the female gender, 2. LVM values, corrected for height 2.7 were not different in both genders even if left ventricular hypertrophy, eccentric in over the 70% of cases, showed a near significant preponderance among females, 3. LVM was significantly related to age and to mean 24-hour systolic and pulse BP, while 24-hour diastolic BP was weakly inversely related with LVM only in the female group, even after adjusting for possible confounders, 4. LVM variance explained by BP values, was on average higher among women than among men, and, once again, 24-hour pulse BP was about sevenfold more important in predicting LVM variance in women than in men, 5. The relative risk of developing LVH adjusted for main confounders, and estimated for every 1mmHg increase, was ~3 times higher in women than in men, either considering the mean 24-hour systolic and pulse BP, 6. Similarly non dipping status was related to a significant higher relative risk of having LVH in women while it wasn t in men.

Women (n=69) Men (n=80) Age (yrs) 51.9±12.6 47.2±11.8 0.02 Height (cm) 161±6 174.9±6.7 0.0001 Weight (Kg) 66.8±10.3 82.1±10.5 0.0001 Body surface area (m 2 ) 1.70±0.13 1.97±0.14 0.0001 BMI (Kg/m 2 ) 25.8±4.1 26.8±3.2 NS 24-h mean systolic BP (mm Hg) 132±12.1 131.1±12.4 NS Office systolic blood pressure (mm Hg) 153.3±24.9 143.9±13.9 0.005 24-h mean diastolic BP (mm Hg) 79.4±11.4 83.7±9.1 0.01 Office diastolic blood pressure (mm Hg) 90.2±11.3 92.2±9.5 NS 24-h mean pulse pressure (mm Hg) 52.3±13.2 46.7±8.3 0.002 Office pulse pressure (mm Hg) 63±20.8 51.8±12.1 0.0001 Heart rate (beats/min) 72±14 68±13 NS Therapy (%) 61 49 NS Obesity (%) 12 15 NS Diabetes (%) 12 8 NS Hypertension (%) 84 81 NS Table 1 Main characteristics of the study population according to gender P

Women (n=69) Men (n=80) Interventricular end-diastolic septal thickness (cm) 1.08±0.8 1.15±0.8 NS Left ventricular end-diastolic diameter (cm) 4.74±0.41 5.07±0.4 0.0001 Posterior wall end-diastolic thickness (cm) 1.08±0.81 1±0.13 0.004 Relative wall thickness (cm) 0.40±0.06 0.39±0.05 NS Left ventricular mass (g) 160±44 197±47 0.0001 Left ventricular mass/body surface area (g/m 2 ) 94.2±24.8 99.9±23.6 NS Left ventricular mass/height 2.7 (g/m 2.7 ) 44.7±13.4 43.9±11.9 NS Left ventricular ejection fraction* 0.65±0.08 0.63±0.08 NS Left ventricular hypertrophy* (%) 61 78 0.06 Eccentric /Concentric hypertrophy (n) 37/5 52/10 NS * Left ventricular mass 47 g/m 2.7 in women and 50 g/m 2.7 in men P Table 2 Echocardiographic findings according to gender

Women (n=69) r P Men (n=80) r Age (yrs) 0.49 0.0001 0.37 0.0007 24-h mean systolic BP (mm Hg) 0.37 0.002 0.34 0.002 Office systolic blood pressure (mm Hg) 0.39 0.001 0.35 0.002 24-h mean diastolic BP (mm Hg) -0.28 0.02 0.14 NS Office diastolic blood pressure (mm Hg) -0.15 NS 0.09 NS 24-h mean pulse pressure (mm Hg) 0.60 0.0001 0.38 0.0004 Office pulse pressure (mm Hg) 0.55 0.0001 0.33 0.003 P Table 3 Correlation cefficients ( r ) between left ventricular mass and age or blood pressure values

a) Women (n=69) Men (n=80) Beta Coefficient P Beta Coefficient P Intercept -43.89356 0.03-48.46927 0.003 Age 0.21193 NS 0.31546 0.007 Body mass index 1.28223 0.0002 1.23103 0.0009 Diabetes 0.06159 NS 13.72345 0.002 Therapy 4.08842 NS 2.78550 NS 24-h mean systolic BP 0.52764 0.0001 0.39614 0.005 24-h mean diastolic BP -0.39668 0.03-0.15106 NS b) Women (n=69) Men (n=80) Beta Coefficient P Beta Coefficient P Intercept -27.90216 0.01-29.09233 0.03 Age 0.17148 NS 0.30694 0.009 Body mass index 1.20897 0.0003 1.27126 0.0008 Diabetes -0.06617 NS 11.87636 0.005 Therapy 4.33241 NS 2.81104 NS 24-h mean pulse pressure 0.49477 0.0002 0.41526 0.003 Table 4 Multiple regression analysis with left ventricular mass as dependent variable, and both 24-h mean BPs a) or 24-h pulse pressure b) as independent variables.

Women (n=69) 95%CI Men (n=80) 95%CI 24-h mean systolic BP (mmhg) 1.214 1.070-1.379 1.082 1.023-1.144 24-h mean diastolic BP (mmhg) 1.108 0.998-1.230 1.083 1.007-1.164 24-h mean pulse pressure (mmhg) 1.244 1.063-1.457 1.090 1.003-1.185 Office systolic blood pressure (mmhg) 1.036 0.996-1.077 1.072 1.009-1.139 Office diastolic blood pressure (mmhg) 1.037 0.964-1.115 1.030 0.964-1.101 Office pulse pressure (mmhg) 1.058 0.998-1.122 1.087 1.018-1.161 Table 5 - Odds Ratio for LV hypertrophy (left ventricular mass 47 g/m 2.7 in women and 50 g/m 2.7 in men) estimated by every 1mmHg increase in blood pressure in both genders after adjusting for age, body mass index, diabetes, and therapy.

% of explained variance 60 50 14.76 40 Other variables 30 20 40.54 35.67 40.77 37.09 24-h mean pulse BP 24-h mean diast. BP 24-h mean syst. BP 10 0 2.94 11.45 0.5 8.53 6.19 Women Men Women Men Figure 1- Percentage of explained variance of left ventricular mass in male and female subjects by 24h mean blood pressure. Other variables are age, body mass index, diabetes, and previous therapy.